Redox Status and Immune Function

October 7, 2016 updated by: Alexandra Sakelliou, National and Kapodistrian University of Athens

Evidence of a Redox-dependent Regulation of Immune Responses to Exercise-Induced Inflammation

In this investigation the investigators utilized N-acetylcysteine (NAC) supplementation to enhance reduced glutathione (GSH) stores during an 8-day recovery period from a strenuous eccentric exercise protocol in order to test the hypotheses: i) redox status perturbations in skeletal muscle are pivotal for the immune responses and ii) antioxidant supplementation may alter immune cell responses following exercise-induced muscle microtrauma.

Study Overview

Detailed Description

The major thiol-disulfide couple of GSH and oxidized glutathione (GSSG) is a crucial regulator of the main transcriptional pathways regulating aseptic inflammation and recovery of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper exercise-induced inflammatory responses.

The objective was to examine how thiol-based antioxidant supplementation affects immune mobilization following exercise-induced skeletal muscle microtrauma. In a two-trial, double-blind, crossover, repeated measures design, 10 young men received either placebo or NAC (20 mg/kg/day) immediately after a muscle-damaging exercise protocol (300 eccentric contractions) and for eight consecutive days. Blood sampling and performance assessment were performed pre-exercise, 2h post-exercise and daily for 8 consecutive days.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Athens, Greece, 11527
        • University of Athens, Medical School, Department of Clinical Therapeutics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Recreationally trained (VO2max > 45 ml/kg/min)
  • Engaged in regular exercise for ≥3 times/week for > 12 months
  • non-smokers
  • Abstain from exercise during the course of the two trials
  • No consumption of performance-enhancing substances, antioxidants, caffeine, alcohol and/or medications during the study.

Exclusion Criteria:

  • NAC intolerance
  • Recent musculoskeletal injuries of the lower limbs
  • Febrile illness
  • History of muscle lesion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: n-acetylcysteine
orally in three daily dosages, at 20 mg/kg/day, daily for eight days after exercise
20 mg//kg/day, orally, daily for eight days following exercise
Other Names:
  • NAC
Active Comparator: Placebo
orally in three daily dosages, content: 500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder
500 mL orally, daily for eight days following exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in protein carbonyls in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Concentration of protein carbonyls
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in thiobarbituric acid reactive substances in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Thiobarbituric acid reactive substances concentration in red blood cells
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in total antioxidant capacity in serum
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in reduced glutathione in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Concentration of reduced glutathione in red blood cells
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in oxidized glutathione in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Concentration of oxidized glutathione in red blood cells
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in catalase activity in red blood cells
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in creatine kinase activity in serum
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in high sensitivity C-reactive protein in serum
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
Changes in white blood cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in adhesion molecule concentration in blood
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
Measurement of soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular cell adhesion molecule-1 (sICAM-1) concentrations in plasma
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise
Changes in cytokine concentration in serum
Time Frame: Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise, 8 days post-exercise
Measurement of interleukin-1β (IL-1β) and interleukin-6 (IL-6)
Pre-exercise, 2 hours post-exercise, 1 day post-exercise, 2 days post-exercise, 3 days post-exercise, 8 days post-exercise
Changes in neutrophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of neutrophil count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in lymphocyte count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of lymphocyte count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in monocyte count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of monocyte count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in basophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of baseophil count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in eosinophil count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of eosinophil count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in T-helper cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of T-helper cell count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in T cytotoxic cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of T cytotoxic cell count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in natural killer-T (NK-T) cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of NK-T cell count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in 62L macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of 62L macrophage count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in B lympho cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of B lympho cell count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in natural killer (NK) cell count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of natural killer cell count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of macrophage count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in HLA+/Macr+ macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of HLA+/Macr+ count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in 11B+ macrophage count in blood
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Cytofluorometric analysis of 11B+ macrophage count in blood
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal aerobic capacity
Time Frame: One day before exercise
Assessment of maximal oxygen consumption
One day before exercise
Changes in muscle performance
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Assessment of maximal knee extensor eccentric peak torque on an isokinetic dynamometer at 60o/s.
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Changes in delayed onset of muscle soreness
Time Frame: Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Assessment of the delayed onset of muscle soreness by palpation of the vastus lateralis and rectus femoris following a squat motion
Pre-exercise, 2 hours post-exercise, daily for 8 consecutive days post-exercise
Body composition
Time Frame: One day before exercise
Measurement of body composition by Dual Emission X-ray Absorptiometry (DXA)
One day before exercise
Changes in dietary intake profile
Time Frame: One day before exercise and daily for 8 consecutive days post-exercise
Assessment of dietary intake with emphasis on antioxidant element intake
One day before exercise and daily for 8 consecutive days post-exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Asimina Mitrakou, Associate Prof., Department of Diabetes and Metabolism Unit of the Department of Clinical Therapeutics, National and Kapodistrian University of Athens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

October 4, 2016

First Submitted That Met QC Criteria

October 7, 2016

First Posted (Estimate)

October 11, 2016

Study Record Updates

Last Update Posted (Estimate)

October 11, 2016

Last Update Submitted That Met QC Criteria

October 7, 2016

Last Verified

October 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skeletal Muscle Damage

Clinical Trials on n-acetylcysteine

3
Subscribe